Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus

E-ISSN： 2160-7648|4|2|121-129

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.2, 2015-03, pp. : 121-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the true risk of a pharmacokinetic drug–drug interaction?

By Fuhr Uwe

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 897-899

Springer Publishing Company

Access to resources Recommend Favorite

Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1738-1766

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Drug–Drug Interaction of the Novel Anticancer Agent E7070 and Acenocoumarol

By van den Bongard H.J.G. Desirée Sparidans Rolf W. Critchley David J.P. Beijnen Jos H. Schellens Jan H.M.

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Lack of Pharmacokinetic Drug-Drug Interaction between Orlistat and Cerivastatin

By Mück W. Adelmann H-G. Ruf T. Unger S. Voith B.

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 71-73

Adis International

Access to resources Recommend Favorite

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite